These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31336382)

  • 1. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease.
    Shi Y; Gu L; Wang Q; Gao L; Zhu J; Lu X; Zhou F; Zhu D; Zhang H; Xie C; Zhang Z
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):664-670. PubMed ID: 31336382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Ashton NJ; Pascoal TA; Karikari TK; Benedet AL; Lantero-Rodriguez J; Brinkmalm G; Snellman A; Schöll M; Troakes C; Hye A; Gauthier S; Vanmechelen E; Zetterberg H; Rosa-Neto P; Blennow K
    Acta Neuropathol; 2021 May; 141(5):709-724. PubMed ID: 33585983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Shekhar S; Kumar R; Rai N; Kumar V; Singh K; Upadhyay AD; Tripathi M; Dwivedi S; Dey AB; Dey S
    PLoS One; 2016; 11(7):e0159099. PubMed ID: 27459603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
    Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF
    J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-Derived Amyloid-β Protein Precursor as a Biomarker of Alzheimer's Disease.
    Wang Q; Shi Y; Qi X; Qi L; Chen X; Shi J; Xie C; Zhang Z
    J Alzheimers Dis; 2022; 88(2):589-599. PubMed ID: 35662121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.
    Spiegel J; Pirraglia E; Osorio RS; Glodzik L; Li Y; Tsui W; Saint Louis LA; Randall C; Butler T; Xu J; Zinkowski RP; Zetterberg H; Fortea J; Fossati S; Wisniewski T; Davies P; Blennow K; de Leon MJ
    J Alzheimers Dis; 2016; 49(1):93-100. PubMed ID: 26444757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
    Shi Y; Gu L; Alsharif AA; Zhang Z
    J Alzheimers Dis; 2017; 59(3):1037-1044. PubMed ID: 28731441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV
    J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet tau pattern correlates with cognitive status in Alzheimer's disease.
    Farías G; Pérez P; Slachevsky A; Maccioni RB
    J Alzheimers Dis; 2012; 31(1):65-9. PubMed ID: 22495344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
    Jia L; Qiu Q; Zhang H; Chu L; Du Y; Zhang J; Zhou C; Liang F; Shi S; Wang S; Qin W; Wang Q; Li F; Wang Q; Li Y; Shen L; Wei Y; Jia J
    Alzheimers Dement; 2019 Aug; 15(8):1071-1080. PubMed ID: 31422798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
    Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of plasma phosphorylated tau231 in detecting Alzheimer's disease: A systematic review with meta-analysis.
    Xu C; Zhao L; Dong C
    Eur J Neurosci; 2023 Aug; 58(4):3132-3149. PubMed ID: 37501373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease.
    Liu HC; Wang HC; Ko SY; Wang PN; Chi CW; Hong CJ; Lin KN; Liu TY
    J Alzheimers Dis; 2007 Mar; 11(1):77-84. PubMed ID: 17361037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study.
    Mukaetova-Ladinska EB; Abdel-All Z; Dodds S; Andrade J; Alves da Silva J; Kalaria RN; O'Brien JT
    Age Ageing; 2012 May; 41(3):408-12. PubMed ID: 22258116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.